# Experimental Human Infection With Neisseria Gonorrhoeae

> **NCT03840811** · PHASE1 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 27 (actual)

## Conditions studied

- Gonococcal Infection

## Interventions

- **DRUG:** Cefixime
- **DRUG:** Ceftriaxone
- **DRUG:** Ciprofloxacin
- **BIOLOGICAL:** Neisseria gonorrhoeae strain FA1090 A26
- **BIOLOGICAL:** Neisseria gonorrhoeae strain FA7537

## Key facts

- **NCT ID:** NCT03840811
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-04-23
- **Primary completion:** 2019-11-25
- **Final completion:** 2019-11-25
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2021-03-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03840811

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03840811, "Experimental Human Infection With Neisseria Gonorrhoeae". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03840811. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*